Fundz

Targepeutics raises strategic investment from Yuvaan Tiwari Foundation to advance GB13 into clinical trials for DIPG.

PRIVATEJul 24, 2025

Round Type

Corporate Round

HummelstownBiotechnologyHealth CareTherapeutics

Investors

Yuvaan Tiwari Foundation

Description

Targepeutics, a biotech company, announces a strategic financing round led by the Yuvaan Tiwari Foundation. This investment supports the advancement of GB13 into clinical trials for treating DIPG. Preclinical data has shown promising efficacy for GB13. The funding aims to expedite operational steps required for the first-in-human trial.

Quick answer

Targepeutics raised an undisclosed amount in a Corporate Round round, dated July 24, 2025. Investors: Yuvaan Tiwari Foundation. Targepeutics is based in Hummelstown, Pennsylvania, United States.

How much did Targepeutics raise?
Targepeutics raised an undisclosed amount in a Corporate Round round on July 24, 2025.
Who invested in Targepeutics?
Yuvaan Tiwari Foundation is named as investors in this round.
What does Targepeutics do?
Targepeutics has an intellectual property portfolio including several issued patents and additional patents pending, focused on novel targeted oncology therapeutics and diagnostics.
Where is Targepeutics based and how big is it?
Targepeutics is based in Hummelstown, Pennsylvania, United States. Fundz records about 3 employees.
Who are the decision-makers at Targepeutics?
Fundz holds 1 contact at Targepeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Targepeutics that raised within 45 days of this round, from Fundz verified event records.

  • MRM Health raised $64M (Series B) on September 4, 2025.
  • TNF Pharmaceuticals raised $7M on September 2, 2025.
  • Os Therapies raised $3.8M on September 2, 2025.
  • Immuneering raised $25M on August 26, 2025.
  • Calidi Biotherapeutics raised $6.9M (Post-IPO Equity) on August 21, 2025.
  • QurAlis raised $20M on August 21, 2025.

Who to call at Targepeutics, and when

A new round usually means Targepeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Targepeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Targepeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Targepeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Targepeutics

Location

Hummelstown, Pennsylvania, United States

About

Targepeutics has an intellectual property portfolio including several issued patents and additional patents pending, focused on novel targeted oncology therapeutics and diagnostics. The company has been awarded Rare Pediatric Disease Designation for GB13 which complements the Orphan Drug Designation for malignant gliomas. The company is completing the required preclinical activities and expects to file an IND for a pediatric first-in-human clinical trial in 1st quarter of 2026.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Targepeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Targepeutics's next move

See what Strategic adds

Targepeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.